A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

NCT02759419 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Adempas (Riociguat, BAY63-2521)

Sponsor

Bayer